ABLE develops lightweight robotic exoskeletons designed for neurorehabilitation, enabling individuals with mobility impairments to regain the ability to walk. The exoskeletons facilitate rapid adjustment and intuitive use, significantly improving therapy efficiency and enhancing the quality of life for users.
Funding
$2.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
H2Founders
Product
Problem
Individuals with mobility impairments often face challenges in accessing effective neurorehabilitation therapies. Traditional rehabilitation methods may be limited by resource constraints, lack of specialized equipment, and the need for intensive therapist involvement. This can hinder the recovery process and limit the potential for regaining motor function.
Solution
ABLE Human Motion develops and markets lightweight robotic exoskeletons designed to enhance neurorehabilitation. The ABLE Exoskeleton actively assists individuals with mobility impairments to walk again, facilitating a more physiological gait pattern. Its rapid adjustment and intuitive design allow for efficient integration into clinical workflows, maximizing therapy time. By providing accessible robotic rehabilitation, ABLE aims to improve mobility, health, and quality of life for patients with neurological conditions.
Target Audience
The primary target audience includes neurorehabilitation clinics and hospitals seeking to offer advanced robotic-assisted therapy to patients with neurological conditions such as stroke, spinal cord injury, and cerebral palsy.
Features
- Lightweight design for comfortable and extended use during therapy sessions
- Rapid donning and doffing, enabling therapists to maximize treatment time
- Intuitive user interface and adaptable settings to accommodate individual patient needs
- Integrated sensors to monitor patient progress and provide real-time feedback
- Facilitates physiological gait patterns to retrain the brain and muscles
- Validated in clinical settings, demonstrating improvements in gait tolerance, motor function, and quality of life